IGF1R and inflammatory bowel disease: Recent research has also demonstrated that the insulin-like growth factor 1, phosphoinositide 3 kinase, protein kinase B, and mammalian target of rapamycin (IGF1/PI3K/Akt/mTOR) axis dysregulation is associated with a decrease in IGF1-R in muscle tissues from IBD patients (63).